Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of “one linked airway disease”
- 29 February 2000
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 84 (2) , 176-187
- https://doi.org/10.1016/s1081-1206(10)62750-0
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of RhinitisAnnals of Allergy, Asthma & Immunology, 1998
- Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced BronchoconstrictionNew England Journal of Medicine, 1998
- Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation.Journal of Clinical Investigation, 1997
- Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitisJournal of Allergy and Clinical Immunology, 1992
- Late Phase Eustachian Tube and Nasal Allergic Responses Associated with Inflammatory Mediator ElaborationAmerican Journal of Rhinology, 1988
- Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.Journal of Clinical Investigation, 1987
- Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humansClinical and Experimental Allergy, 1986
- Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects.Thorax, 1984
- Asthma and Allergic Rhinitis in the Same PatientsAllergy, 1983
- Late bronchial obstructive reaction to experimental inhalation of house dust extractClinical and Experimental Allergy, 1972